| 出品公司: | ZYbscience |
|---|---|
| 载体名称: | pLKO-DEST-EGFP |
| 质粒类型: | 慢病毒载体;RNAi载体;cDNA/shRNA gateway |
| 高拷贝/低拷贝: | 低拷贝 |
| 克隆方法: | gateway |
| 启动子: | U6 |
| 载体大小: | 8856 bp |
| 5' 测序引物及序列: | LKO.1 5' :GACTATCATATGCTTACCGT |
| 3' 测序引物及序列: | -- |
| 载体标签: | -- |
| 载体抗性: | 氨苄青霉素、氯霉素 |
| 筛选标记: | Hygromycin |
| 克隆菌株: | 阳性筛选用DB3.1 ,阴性筛选用OmniMAX2-T1, 重组慢病毒载体的复制用Stbl3感受态细胞,以维持质粒的稳定性。 |
| 宿主细胞(系): | 哺乳动物细胞 |
| 备注: | 其它筛选标 |
| 产品目录号: | ZY 32684 |
| 稳定性: | 稳表达 |
| 组成型/诱导型: | 组成型 |
| 病毒/非病毒: | 慢病毒 |
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-20℃低温保存
- 保质期:
三年
- 英文名:
pLKO-DEST-EGFP
- 库存:
20
- 供应商:
泽叶生物
载体基本信息
载体质粒图谱和多克隆位点信息

载体简介
载体序列
LOCUS pLKO-DEST-EGFP 8856 bp DNA SYN
ACCESSION
KEYWORDS
SOURCE
ORGANISM other sequences; artificial sequences; vectors.
FEATURES Location/Qualifiers
source 1..8856
/organism="pLKO.DEST.EGFP"
/mol_type="other DNA"
misc_feature complement(114..221)
/label="attR1"
misc_feature 114..214
/label="attR2"
CDS 241..747
/label="ORF frame 1"
/translation="MGGRSRGPKLTREFSTSRQMAVFIHNFKRKGGIGGYSAGERIVD
IIATDIQTKELQKQITKIQNFRVYYRDSRDPLWPRLEGVGVAPFPRLEFYRVGEALFP
RQSGACALAAPLGTWRYTSGLWPRTHSTSTGRRQPAPFFGGPFAPPSTPPLVRKFPPA
PQLASCRT*"
misc_feature 322..337
/label="cPPT"
/translation="MGGRSRGPKLTREFSTSRQMAVFIHNFKRKGGIGGYSAGERIVD
IIATDIQTKELQKQITKIQNFRVYYRDSRDPLWPRLEGVGVAPFPRLEFYRVGEALFP
RQSGACALAAPLGTWRYTSGLWPRTHSTSTGRRQPAPFFGGPFAPPSTPPLVRKFPPA
PQLASCRT*"
misc_feature complement(559..582)
/label="MSCV_rev_primer"
/translation="MGGRSRGPKLTREFSTSRQMAVFIHNFKRKGGIGGYSAGERIVD
IIATDIQTKELQKQITKIQNFRVYYRDSRDPLWPRLEGVGVAPFPRLEFYRVGEALFP
RQSGACALAAPLGTWRYTSGLWPRTHSTSTGRRQPAPFFGGPFAPPSTPPLVRKFPPA
PQLASCRT*"
CDS 804..1928
/label="ORF frame 3"
/translation="MEAGRPLGQRPIAALLLRFLGSEAGKGWVRGRAQGRAQGRGGRP
KVLRRPGILHASKAHVCRAVLLFLISGPFDLQPKLAYHDRVQAHGAPRHPRRRPQGRT
HPRRRVRRLPRHAPHRRSGPNHNHGEQGRGAVHRGGAHPGRAGRRRKRPQVQRVRRGR
GRCHLRQADPEVHLHHRQAARALAHPRDHPDLRRAVLQPLPRPHEAARLLQVRHARRL
RPGAHHLLQGRRQLQDPRRGEVRGRHPGEPHRAEGHRLQGGRQHPGAQAGVQLQQPQR
LYHGRQAEERHQGELQDPPQHRGRQRAARRPLPAEHPHRRRPRAAARQPLPEHPVRPE
QRPQREARSHGPAGVRDRRRDHSRHGRAVQVKRPHMHRYL*"
misc_feature 956..975
/label="mPGK_F_primer"
/translation="MEAGRPLGQRPIAALLLRFLGSEAGKGWVRGRAQGRAQGRGGRP
KVLRRPGILHASKAHVCRAVLLFLISGPFDLQPKLAYHDRVQAHGAPRHPRRRPQGRT
HPRRRVRRLPRHAPHRRSGPNHNHGEQGRGAVHRGGAHPGRAGRRRKRPQVQRVRRGR
GRCHLRQADPEVHLHHRQAARALAHPRDHPDLRRAVLQPLPRPHEAARLLQVRHARRL
RPGAHHLLQGRRQLQDPRRGEVRGRHPGEPHRAEGHRLQGGRQHPGAQAGVQLQQPQR
LYHGRQAEERHQGELQDPPQHRGRQRAARRPLPAEHPHRRRPRAAARQPLPEHPVRPE
QRPQREARSHGPAGVRDRRRDHSRHGRAVQVKRPHMHRYL*"
CDS 1048..1899
/label="ORF frame 1"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
gene 1183..1896
/label="EGFP"
/gene="EGFP"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature complement(1225..1246)
/label="EGFP_N_primer"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 1363..1392
/label="Y66 (EGFP)"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 1833..1854
/label="EGFP_C_primer"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 1972..1987
/label="cPPT"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 1972..1993
/label="U3PPT"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 1989..2041
/label="delta_U3"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 2042..2222
/label="HIV-1_5_LTR"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 2042..2222
/label="truncHIV-1_3_LTR"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
terminator 2297..2416
/label="SV40_PA_terminator"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 2385..2404
/label="EBV_rev_primer"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
rep_origin 2434..2532
/label="SV40_origin"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
misc_feature 2517..2536
/label="SV40pro_F_primer"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
rep_origin 2748..3054
/label="f1_origin"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
promoter 3247..3275
/label="AmpR_promoter"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
gene 3317..4177
/label="Ampicillin"
/gene="Ampicillin"
/translation="MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRTTT
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW
PTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIED
GSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK*"
CDS 3317..4177
/label="ORF frame 2"
/translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGY
IELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVE
YSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRL
DRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPL
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIA
EIGASLIKHW*"
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验-MEM、DMEM培养基和M-MLV逆转录酶;小牛血清;G418;DIG High PrimeDNA Labeling and Detection Starter Kit I1。 质粒 pGL3-promoter;含EBVR的质粒p220.2。 重组质粒载体pcDNA3-EGFP-EBVR的构建 采用StuI和XbaI消化p220.2,获得长4.7 kb的EBVR,包括EBV核抗原1(EBNA1)和OriP,克隆至pGL3-promotor的SV40启动子下游Hind Ill
静脉注射,病毒注射总量为 1×10^11 vg/小鼠。Luc 的表达由 cTnT 启动子控制。(DOI: 10.1038/gt.2010.105) 图 4. 五种 AAV 血清型在小鼠体内的心脏基因递送效率比较。注射方式为左心室前壁注射,病毒注射总量为 5×10^10 vg/小鼠,体积为 10μL。Luc 的表达由 cTnT 启 动子控制。(DOI:10.1002/jgm.1576) 图 5. 五种 AAV 血清型以不同剂量注射至小鼠体内的心脏基因递送效率比较。注射方式为颈静脉注射。EGFP
polIII型启动子和终止子序列,RNAi靶序列克隆进入后将在哺乳动物细胞中形成shRNA。目的载体(destinationvector)Gateway®适合的目的载体(DEST)包含attR位点,可以与入门克隆进行重组,构建表达载体。BLOCK-iT™RNAi慢病毒和腺病毒DEST载体接受来自U6入门载体的RNAi框。此外,也有在原核、酵母、昆虫或者哺乳动物系统表达天然蛋白或者融合蛋白的DEST载体可供选择。LRClonase™便于attL和attR位点在LxRGateway®重组反应中进行重组的一种酶
技术资料暂无技术资料 索取技术资料




